Anti-TNFRSF9/4-1BB/CD137 Antibody (Utomilumab)
Catalog No.
F1067
Anti-TNFRSF9/4-1BB/CD137 Antibody (Utomilumab)
Featured Products
Utomilumab (PF 05082566) is a humanized IgG2 mAb agonist targeting the T cell co-stimulatory receptor 4-1BB/CD137. Utomilumab is being investigated in patients with relapsed/refractory follicular lymphoma (FL) and other CD20+ non-Hodgkin lymphomas (NHL).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
142.78 kDa
Dry ice
1417318-27-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
PF-5082566, F-2566
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q07011
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human TNFRSF9 / 4-1BB / CD137, His Tag at 2 ug/mL can bind utomilumab
TNFRSF9 / 4-1BB / CD137
Please avoid freeze-thaw cycles.